Raised S.B. No. 202
Session Year 2024


AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING PRESCRIPTION DRUG CONTROL.

To: (1) Allow a licensed manufacturer or wholesaler to sell a hypodermic needle or syringe to an advanced practice registered nurse, optometrist or physician assistant; (2) redefine "commissioner", "pharmaceutical manufacturer" and "pharmaceutical marketing firm" for the purposes of various statutes concerning pharmaceutical marketing; (3) eliminate a requirement that the Department of Consumer Protection annually analyze certain information submitted to the department concerning pharmaceutical marketing; (4) extend the date by which the department is required to submit an annual report concerning pharmaceutical marketing; (5) eliminate an overlapping prohibition concerning automatic reciprocal discipline of pharmacists; (6) modify the actions the Commissioner of Consumer Protection may take following a violation of certain statutes concerning pharmaceutical marketing; (7) require certain practitioners that dispense, administer or prescribe controlled substances to make certain records available to the department; and (8) make minor, technical and conforming changes to various statutes concerning prescription drug control.


Other Bills with Similar Topics